Correlation Between 896215AH3 and Neurocrine Biosciences

Can any of the company-specific risk be diversified away by investing in both 896215AH3 and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 896215AH3 and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between US896215AH37 and Neurocrine Biosciences, you can compare the effects of market volatilities on 896215AH3 and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 896215AH3 with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of 896215AH3 and Neurocrine Biosciences.

Diversification Opportunities for 896215AH3 and Neurocrine Biosciences

-0.78

Correlation Coefficient

896215AH3  Neurocrine Biosciences

Pay attention - limited upside

The 3 months correlation between 896215AH3 and Neurocrine is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding US896215AH37 and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and 896215AH3 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on US896215AH37 are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of 896215AH3 i.e., 896215AH3 and Neurocrine Biosciences go up and down completely randomly.

Pair Corralation between 896215AH3 and Neurocrine Biosciences

Assuming the 90 days trading horizon US896215AH37 is expected to under-perform the Neurocrine Biosciences. But the bond apears to be less risky and, when comparing its historical volatility, US896215AH37 is 1.81 times less risky than Neurocrine Biosciences. The bond trades about -0.07 of its potential returns per unit of risk. The Neurocrine Biosciences is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  11,522  in Neurocrine Biosciences on September 29, 2024 and sell it today you would earn a total of  2,422  from holding Neurocrine Biosciences or generate 21.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	82.54%
Values	Daily Returns

US896215AH37  vs.  Neurocrine Biosciences

US896215AH37

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days US896215AH37 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 896215AH3 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Neurocrine Biosciences

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with 896215AH3 and Neurocrine Biosciences

The main advantage of trading using opposite 896215AH3 and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 896215AH3 position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.

The idea behind US896215AH37 and Neurocrine Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.